Non-Adherence to Antiplatelet Therapy After PCI Ups Risk of MACE in Anemic Patients Non-Adherence to Antiplatelet Therapy After PCI Ups Risk of MACE in Anemic Patients

In anemic patients who have undergone percutaneous coronary intervention (PCI), non-adherence to dual antiplatelet therapy (DAPT) - but not physician-recommended discontinuation - is associated with a higher risk of major adverse cardiovascular events (MACE) in the two years following the procedure, researchers say.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news